e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
A more functional view of chest pathology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary artery diameter but not diameter ratio is indicative of pulmonary hypertension in systemic sclerosis
M. Els Bakker (Leiden, Netherlands), Els Bakker, Maarten Ninaber, Jan Stolk, Lucia Kroft, Anne Schouffoer, Berend Stoel
Source:
International Congress 2015 – A more functional view of chest pathology
Session:
A more functional view of chest pathology
Session type:
Thematic Poster Session
Number:
3742
Disease area:
Interstitial lung diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Els Bakker (Leiden, Netherlands), Els Bakker, Maarten Ninaber, Jan Stolk, Lucia Kroft, Anne Schouffoer, Berend Stoel. Pulmonary artery diameter but not diameter ratio is indicative of pulmonary hypertension in systemic sclerosis. Eur Respir J 2015; 46: Suppl. 59, 3742
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Imaging of complicated pneumonia: what is new?
Related content which might interest you:
Pulmonary artery dilation and increased lung density in systemic sclerosis
Source: International Congress 2015 – A more functional view of chest pathology
Year: 2015
Pulmonary artery dissection (PAD) in a patient with diffuse interstitial lung disease and chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016
Pulmonary artery diameter to predict pulmonary hypertension in pulmonary sarcoidosis
Source: Eur Respir J 2016; 47: 673-676
Year: 2016
Unique characteristics of patients with pulmonary arterial hypertension associated with congenital heart disease compared to the rest of pulmonary arterial hypertension subgroups
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014
Non-invasive haemodynamic measurement to detect treatment response in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
CT measured pulmonary artery to aorta ratio as a predictor of pulmonary hypertension in COPD
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Right ventricular dysfunction in pulmonary hypertension with combined pulmonary fibrosis and emphysema syndrome
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013
Pulmonary vascular reactivity in pulmonary hypertension due to left heart disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
Myocardial perfusion in patients with pulmonary hypertension of different etiology
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015
Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy
Source: Eur Respir J 2009; 33: 371-379
Year: 2009
Sildenafil decreases the contractile response to serotonin (5HT) in pulmonary arteries from patients with idiopathic pulmonary fibrosis (IPF) and pulmonary hypertension (PH)
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Pulmonary hypertension and multiple pulmonary nodules caused by tumor of pulmonary artery (PA)
Source: Eur Respir J 2006; 28: Suppl. 50, 127s
Year: 2006
Mean pulmonary artery pressure using echocardiography in chronic thromboembolic pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016
Pulmonary hypertension associated with sarcoidosis
Source: Eur Respir Mon 2012; 57: 166-181
Year: 2012
Lung function and pulmonary hypertension in systemic sclerosis
Source: Eur Respir J 2006; 28: Suppl. 50, 548s
Year: 2006
Pulmonary arterial lesions and interstitial remodeling patterns in histology differentiate EIF2AK4 mutation-carriers from non-carriers with pulmonary veno-occlusive disease
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
Pulmonary vascular distensibility in pulmonary hypertension due to left heart disease
Source: International Congress 2018 – Pulmonary hypertension: right ventricle function, haemodynamics and exercise
Year: 2018
Ratio of pulmonary arterial to aortic diameter and right to left ventricular diameter associate with poor outcome in medically-treated chronic thromboembolic pulmonary hypertension
Source: International Congress 2015 – A more functional view of chest pathology
Year: 2015
Pulmonary hypertension in idiopathic pulmonary fibrosis: Utility of HRCT
Source: International Congress 2014 – COPD and PAH related imaging
Year: 2014
Relation between pulmonary arterial remodeling and parenchymal disease in severe COPD and interstitial lung disease patients
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept